Current Report Filing (8-k)
September 30 2022 - 6:01AM
Edgar (US Regulatory)
0001725430
false
0001725430
2022-09-28
2022-09-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported): September 28 , 2022
GBS
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-39825 |
|
82-1512711 |
(State
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
employer identification no.) |
WeWork
c/o GBS Inc.
142
West, 57th Street, 11th
Floor
New
York, NY 10019
(Address
of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: (646) 828-8258
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, $0.01 par value |
|
GBS |
|
The
NASDAQ Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
(e)
On September 28, 2022, GBS Inc., through its subsidiary GBS (APAC) Pty Ltd (the “Company”), entered into an employment agreement
with Dr. Steven Boyages, Interim Chief Executive Officer and Chairman of the Company (the “Boyages Employment Agreement”).
The Boyages Employment Agreement complements the letter for directorship dated December 23, 2020. This compensates him for his additional
responsibility to oversee the operations of the Company as approved by the Company’s Compensation Committee.
In
accordance with the Boyages Employment Agreement, Dr. Boyages receives an annual salary of $82,668, in addition to his directors’
fees of $36,363 for his role as the Chairman of the Company.
In
addition, Dr. Boyages is eligible to receive an annual bonus of up to 20% of his gross base salary. The Company also makes certain contributions
that are mandatory in Australia to a retirement fund for Dr. Boyages, known in Australia as a superannuation fund, currently at the rate
of 10.5% subject to contribution cap of $18,944 per annum.
The
Boyages Employment Agreement is terminable on six months’ notice either by the Company or by Dr. Boyages. However, the Company
may terminate Dr. Boyages without notice if he engages in serious or willful misconduct, is seriously negligent in the performance of
his duties, commits a serious or persistent breach of the Boyages Employment Agreement, brings the Company into disrepute or is convicted
of a criminal offense.
The
Boyages Employment Agreement contains provisions protecting the Company’s confidential information and intellectual property. The
Boyages Employment Agreement also contains provisions restricting Dr. Boyages’ ability to compete with the Company during his employment
and for a period of up to six months thereafter in a specified geographic region. The non-compete provisions will generally impose restrictions
on inducing the Company’s employees to leave the Company’s employment or soliciting clients of the Company.
The
foregoing description of the Boyages Employment Agreements is not complete and is qualified in its entirety by reference to the full
text of the Boyages Employment Agreement, which is attached to this report as Exhibit 10.1, and are incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
September 29, 2022 |
|
|
|
GBS
INC. |
|
|
|
|
By:
|
/s/
Spiro Sakiris |
|
Name:
|
Spiro
Sakiris |
|
Title: |
Chief
Financial Officer |
GBS (NASDAQ:GBS)
Historical Stock Chart
From Jun 2024 to Jul 2024
GBS (NASDAQ:GBS)
Historical Stock Chart
From Jul 2023 to Jul 2024